Racial variation in the development of posttransplant lymphoproliferative disorders after renal transplantation

Robert Nee*, Frank P. Hurst, Vikas R. Dharnidharka, Rahul M. Jindal, Lawrence Y. Agodoa, Kevin C. Abbott

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Background. We previously reported that posttransplant lymphoproliferative disorders (PTLD) occurred more frequently in non-African American (AF) kidney transplant recipients. An in-depth analysis of racial differences in the development of PTLD has not been reported. Methods. We assessed Medicare claims for PTLD in a retrospective cohort of 53,719 patients who underwent transplantation from January 2000 to September 2006 and followed up through December 2007. Results. There were 719 (1.3%) patients with claims for PTLD. Non-AF recipient race (including all races analyzed separately, adjusted hazard ratio [AHR] 1.38, 95% confidence interval [CI] 1.13-1.68), recipient Epstein-Barr virus (EBV) immunoglobulin G (IgG) seronegative status (AHR 1.88, 95% CI 1.53-2.34), and de novo sirolimus (AHR 1.22, 95% CI 1.03-1.45) were associated with an increased risk of PTLD. Furthermore, de novo sirolimus showed a significant interaction with EBV IgG; among EBV IgG-negative recipients, sirolimus use was significant (P=0.003), but among EBV IgG-positive recipients, it was not significant (P=0.18). EBV IgG-seronegative status was significant in all races except for AFs, and racial differences were a significant effect modifier for EBV IgG status and risk of PTLD. Mortality subsequent to PTLD did not differ by race. Conclusions. AF kidney transplant recipients were at lower risk for PTLD, irrespective of the recipient EBV IgG serostatus. On the contrary, recipient EBV IgG-seronegative status was associated with a higher risk of PTLD in the non-AF population. De novo sirolimus therapy was associated with increased risk of PTLD in EBV IgG-negative recipients, regardless of race.

Original languageEnglish
Pages (from-to)190-195
Number of pages6
Issue number2
StatePublished - 27 Jul 2011
Externally publishedYes


  • Cancer
  • Renal transplantation
  • United States Renal Data System


Dive into the research topics of 'Racial variation in the development of posttransplant lymphoproliferative disorders after renal transplantation'. Together they form a unique fingerprint.

Cite this